Zentalis Pharmaceuticals, Inc. (ZNTL)
3.80
-0.08
(-2.06%)
USD |
NASDAQ |
Aug 28, 16:00
3.80
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Total Liabilities (Quarterly) : 71.68M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 71.68M |
| March 31, 2026 | 70.39M |
| December 31, 2025 | 72.76M |
| September 30, 2025 | 74.38M |
| June 30, 2025 | 77.21M |
| March 31, 2025 | 88.64M |
| December 31, 2024 | 93.15M |
| September 30, 2024 | 96.33M |
| June 30, 2024 | 109.10M |
| March 31, 2024 | 98.71M |
| December 31, 2023 | 124.64M |
| September 30, 2023 | 103.82M |
| June 30, 2023 | 98.16M |
| March 31, 2023 | 103.68M |
| Date | Value |
|---|---|
| December 31, 2022 | 119.43M |
| September 30, 2022 | 100.46M |
| June 30, 2022 | 95.03M |
| March 31, 2022 | 90.01M |
| December 31, 2021 | 107.54M |
| September 30, 2021 | 41.08M |
| June 30, 2021 | 36.35M |
| March 31, 2021 | 35.72M |
| December 31, 2020 | 32.82M |
| September 30, 2020 | 27.40M |
| June 30, 2020 | 19.29M |
| March 31, 2020 | 176.82M |
| December 31, 2019 | 19.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 236.98M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 215.33M |
| Shareholders Equity (Quarterly) | 143.65M |
| Debt to Equity Ratio | 0.2624 |
| Current Ratio | 4.818 |
| Net Debt Paydown Yield | 0.06% |